NCT05711615 2026-04-13Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaNational Cancer Institute (NCI)Phase 1 Recruiting30 enrolled